Attachments

PPhynwire

European market disclosures, company announcements, and official source documents.

Terms Latest releasesEN

Information service only. Not investment advice.

Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.: Prisca Anand, buy | Phynwire

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.: Prisca Anand, buy

Original source on eqs-news.com

Language:EnglishDE

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
12.08.2026 / 16:35 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated
a) Name

Title:
First name:	Prisca
Last name(s):	Anand

2. Reason for the notification
a) Position / status

Person closely associated with:
Title:
First name:	Ravi
Last name(s):	Anand
Position:	Member of the managing body

b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name

Newron Pharmaceuticals S.p.A.

b) LEI

8156002F8C11F80A9740

4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	IT0004147952

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
11.973315 CHF	16,978.00 CHF

d) Aggregated information

Price	Aggregated volume
11.9733 CHF	16,978.00 CHF

e) Date of the transaction

10/08/2026; UTC+2

f) Place of the transaction

Name:	SIX Swiss Exchange
MIC:	XSWX

12.08.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Language:	English
Company:	Newron Pharmaceuticals S.p.A.
	via Antonio Meucci 3
	20091 Bresso
	Italy
Internet:	www.newron.com
LEI Code:	8156002F8C11F80A9740


End of News	EQS News Service

106532 12.08.2026 CET/CEST